We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+11.44%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$96.2B
AUM Growth
+$13.8B
(+17%)
Cap. Flow
+$2.5B
Cap. Flow
% of AUM
2.6%
Top 10 Holdings %
Top 10 Hldgs %
19.24%
Holding
5,235
New
767
Increased
1,692
Reduced
1,826
Closed
817
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$410M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$308M |
| 3 |
Eli Lilly
LLY
|
+$292M |
| 4 |
Costco
COST
|
+$291M |
| 5 |
Ford
F
|
+$257M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$368M |
| 3 |
Fair Isaac
FICO
|
+$197M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$194M |
| 5 |
Carrier Global
CARR
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.55% |
| 2 | Consumer Discretionary | 7.1% |
| 3 | Financials | 4.87% |
| 4 | Healthcare | 4.79% |
| 5 | Industrials | 4.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4051
CALL
Recursion Pharmaceuticals
RXRX
$1.57B
| $152K | ﹤0.01% |
30,000
-28,000
| -48% | -$138K |
|
4052
Star Holdings Shares of Beneficial Interest
STHO
$112M
| $151K | ﹤0.01% |
19,310
+7,114
| +58% | +$49.2K |
|
4053
RPC Inc
RES
$1.24B
| $150K | ﹤0.01% |
+31,795
| New | +$153K |
|
4054
Atossa Therapeutics
ATOS
$22.8M
| $150K | ﹤0.01% |
12,074
-19,859
| -62% | -$237K |
|
4055
Alto Neuroscience
ANRO
$1.04B
| $149K | ﹤0.01% |
67,948
+51,384
| +310% | +$122K |
|
4056
Zumiez
ZUMZ
$320M
| $148K | ﹤0.01% |
11,176
-1,570
| -12% | -$19.8K |
|
4057
SunCoke Energy
SXC
$757M
| $148K | ﹤0.01% |
17,226
-6,842
| -28% | -$59.3K |
|
|
UHG
4058
DELISTED
United Homes Group
UHG
| $147K | ﹤0.01% |
50,765
+34,338
| +209% | +$89.3K |
|
|
XRN
4059
Chiron Real Estate Inc
XRN
$544M
| $147K | ﹤0.01% |
+4,243
| New | +$148K |
|
4060
Theravance Biopharma
TBPH
$874M
| $147K | ﹤0.01% |
13,322
-10,445
| -44% | -$102K |
|
4061
Cardlytics
CDLX
$21M
| $147K | ﹤0.01% |
+8,912
| New | +$154K |
|
4062
Crawford & Co Class A
CRD.A
$536M
| $147K | ﹤0.01% |
+13,850
| New | +$147K |
|
|
FFWM
4063
DELISTED
First Foundation Inc
FFWM
| $146K | ﹤0.01% |
28,722
-76,661
| -73% | -$392K |
|
4064
Elanco Animal Health
ELAN
$12.4B
| $146K | ﹤0.01% |
10,254
| – | – |
|
4065
CALL
Enovix
ENVX
$862M
| $146K | ﹤0.01% |
16,114
-267,657
| -94% | -$1.75M |
|
4066
Arcos Dorados Holdings
ARCO
$1.73B
| $143K | ﹤0.01% |
18,177
-45,310
| -71% | -$343K |
|
4067
Cosan
CSAN
$2.96B
| $143K | ﹤0.01% |
+28,347
| New | +$153K |
|
4068
Arq
ARQ
$86.7M
| $142K | ﹤0.01% |
26,434
-97,943
| -79% | -$429K |
|
4069
BW LPG
BWLP
$3.31B
| $142K | ﹤0.01% |
+11,999
| New | +$128K |
|
|
TRTX
4070
TPG RE Finance Trust
TRTX
$666M
| $141K | ﹤0.01% |
18,262
-9,849
| -35% | -$75.1K |
|
4071
Jasper Therapeutics
JSPR
$22.9M
| $141K | ﹤0.01% |
+25,379
| New | +$125K |
|
|
LNKB
4072
DELISTED
LINKBANCORP
LNKB
| $141K | ﹤0.01% |
+19,234
| New | +$132K |
|
4073
SelectQuote
SLQT
$114M
| $140K | ﹤0.01% |
58,862
+24,667
| +72% | +$64.7K |
|
4074
NRX Pharmaceuticals
NRXP
$161M
| $138K | ﹤0.01% |
+42,202
| New | +$106K |
|
4075
CALL
AMC Entertainment Holdings
AMC
$2.03B
| $137K | ﹤0.01% |
44,200
-13,100
| -23% | -$38.9K |
|
Similar funds
Squarepoint's Q2 2025 Portfolio in Review
As of Q2 2025, Squarepoint held 5,235 positions worth $96.2B, up 17% from $82.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Squarepoint's Q2 2025 filing shows 767 new, 1,692 increased, 1,826 reduced and 817 closed positions. Its largest new stake was iShares MSCI EAFE ETF: 993,060 shares worth $88.8M. The largest sale was Microsoft, an estimated $1.48B.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Financials.
- Squarepoint's largest Q2 2025 buy was iShares MSCI EAFE ETF: 993,060 shares worth $88.8M.
- Squarepoint added most to Amazon in Q2 2025, an estimated $410M increase.
- Squarepoint's biggest Q2 2025 reduction was Microsoft, cutting an estimated $1.48B.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q2 2025, selling an estimated $194M.
- Squarepoint's ten largest holdings make up 19% of its $96.2B portfolio in Q2 2025.
- Squarepoint opened 767 new positions and closed 817 in Q2 2025.
- Squarepoint's portfolio value rose 17% quarter-over-quarter to $96.2B.
Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.